Botanicals and Acupuncture - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The botanicals and acupuncture market size is expected to increase from USD 78.02 billion in 2025 to USD 93.51 billion in 2026 and reach USD 231.23 billion by 2031, growing at a CAGR of 19.85% over 2026-2031. This report is Segmented by Intervention (Botanicals, Acupuncture), Application (Pain Management, Stress Relief, Rehabilitation, Women's Health, GI Wellness, Immunity), End User (Hospitals, Wellness Centers, Home Care, Ascs, TCM Clinics), Distribution Channel (Direct Sales, E-Sales, Pharmacies), and Geography (North America, Europe, Asia-Pacific, and More). Value (USD) Forecasts are Provided.

Global Botanicals and Acupuncture Market Trends and Insights

Rising Preference for Natural and Drug-Free Therapies

The botanicals and acupuncture market is seeing stronger demand from consumers who want plant-based products and non-drug treatment options in routine health management. Retail sales of herbal dietary supplements in the United States reached USD 13.23 billion in 2024, rising 5.4% from the prior year and showing that demand moved well beyond a niche wellness base. The botanicals and acupuncture market is also drawing strength from new product mix changes, with mushroom-based botanicals entering the retail top 40 for the first time in 2024 after a 76% sales increase. That shift matters because it shows newer functional formats are now adding demand rather than relying only on established herbal categories. The botanicals and acupuncture market benefits when these products and therapies become normal first-step choices for everyday stress, immune support, and general wellness needs.

Growing Clinical Acceptance of Integrative Pain Management

The botanicals and acupuncture market is gaining support as more health systems place integrative care into regular service lines rather than separate wellness programs. A June 2025 NEJM Catalyst survey found that 35% of U.S. healthcare organizations offered acupuncture or acupressure, compared with 15% outside the United States. The same survey found that 93% of respondents said integrative care improves patient experience, which shows why providers keep these services in place even when budgets are tight. The botanicals and acupuncture market is also helped by the fact that 71% of respondents saw reimbursement stay unchanged, yet providers still continued offering care, which points to demand that is already strong inside institutions. As more hospitals use these therapies to improve pain pathways and patient experience, the botanicals and acupuncture market is likely to see broader procurement of botanical products and acupuncture-related supplies.

Regulatory Fragmentation Across Botanical and Acupuncture Offerings

The botanicals and acupuncture market still lacks a common cross-border framework for product rules, clinical standards, and market access pathways. The World Health Organization said in October 2025 that the WHO International Regulatory Cooperation for Herbal Medicines meeting advanced work on the WHO International Herbal Pharmacopoeia and the Global Traditional Medicine Strategy 2025-2034. That progress is important, but it also shows that harmonization is still a work in progress rather than a finished operating environment. The botanicals and acupuncture market therefore continues to face higher compliance costs, slower product rollout, and uneven evidence expectations from one country to another. Until common rules become more practical across regions, the botanicals and acupuncture market will keep favoring larger companies that can manage separate dossiers, quality systems, and approval processes.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of E-Commerce and DTC Access for Botanical Products
• Rising Insurance and Reimbursement Support for Acupuncture in Select Markets
• Practitioner Shortage and Non-Uniform Certification Standards

Segment Analysis

Botanicals accounted for 68.31% of botanicals and acupuncture market share in 2025, showing how much of the revenue base still sits in herbal supplements, plant extracts, essential oils, and botanical drugs. Herbal supplements remain the largest commercial layer within this segment because they combine wide consumer familiarity with recurring demand in daily wellness routines. U.S. retail sales of herbal dietary supplements reached a significant sale in 2024, while mushroom-based botanicals posted 76% growth and entered the retail top 40 for the first time, reinforcing the strength of newer functional formats. Within the botanicals and acupuncture industry, this wide product span gives botanicals a larger installed base than the procedure-led acupuncture segment.

Acupuncture is forecast to grow at 21.38% CAGR through 2031, making it the fastest-moving intervention type in the botanicals and acupuncture market. Traditional acupuncture and electroacupuncture still account for the core clinical volume because they fit more established treatment pathways in pain, rehabilitation, and supportive care. Laser acupuncture and dry needling are expanding in sports medicine and physical therapy settings where treatment protocols are widening. A Frontiers in Medicine review published in April 2026 reported AI-guided systems with 97.5% accuracy in facial acupoint identification using YOLOv8-pose models, showing how software support is starting to shape the next layer of practice development. Auricular acupuncture and acupressure are also gaining ground in home care, which extends the botanicals and acupuncture market beyond clinic-only use and gives the segment a longer growth runway.

Pain management held 35.24% share in 2025, which kept it as the largest application in the botanicals and acupuncture market. That position reflects years of clinical use and a clear fit with non-drug care pathways for chronic pain. Botanical analgesics such as boswellia, willow bark, and curcumin remain closely tied to this use case, while acupuncture continues to hold a practical role in pain-focused treatment programs. Rehabilitation also keeps a meaningful place in the mix, and a 2025 ScienceDirect study cited 93.6% accuracy in predicting upper limb function recovery after ischemic stroke from acupuncture treatment data, supporting continued clinical interest in recovery-related applications.

Stress and anxiety relief is projected to grow at 22.52% CAGR through 2031, giving it the fastest expansion pace among applications in the botanicals and acupuncture market. Kracie Pharmaceutical reported in December 2025 that demand for the stress-related kampo formulation Kamikihito grew most strongly among adults in their 20s, with social media playing an important awareness role. That pattern matters because it shows a younger demand base entering the category through emotional well-being rather than only physical symptom management. Adaptogens such as ashwagandha and rhodiola remain the main botanical expressions of this demand, while acupressure and auricular acupuncture fit well with home-use stress relief. The faster pace in this application also reflects lower historical penetration in formal care settings, which leaves more room for the botanicals and acupuncture market to add new use cases over time.

Complete Report Scope:

• By Intervention
  • Botanicals
    • Herbal Supplements
    • Medicinal Plants
    • Essential Oils
    • Plant-Based Extracts
    • Botanical Drugs
    • Others
  • Acupuncture
    • Traditional Acupuncture
    • Electroacupuncture
    • Dry Needling
    • Auricular Acupuncture
    • Scalp Acupuncture
    • Laser Acupuncture
    • Acupressure
• By Application
  • Pain Management
  • Stress and Anxiety Relief
  • Rehabilitation
  • Women's Health and Fertility
  • Gastrointestinal Wellness
  • Immunity Support
  • Other Applications
• By End User
  • Hospitals and Specialty Clinics
  • Wellness and Rehabilitation Centers
  • Home Care
  • Ambulatory Surgical Centers
  • Traditional Medicine Clinics
  • Other End Users
• By Distribution Channel
  • Direct Sales
  • E-Sales
  • Pharmacies and Drug Stores
  • Other Distribution Channels
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 36.22% of botanicals and acupuncture market share in 2025, making it the largest regional contributor. The United States remains the anchor because it combines stronger integrative care infrastructure with broader institutional awareness than most other regions. In the June 2025 NEJM Catalyst survey, 35% of U.S. healthcare organizations offered acupuncture or acupressure and 93% said integrative care improves patient experience, which points to a solid clinical base for continued demand. New York's April 2026 move to require acupuncture coverage under large group insurance policies adds a more supportive reimbursement backdrop for one of the country's largest insured populations. Canada and Mexico add regional depth through consumer interest in botanical care and traditional medicine use, even though the United States still sets the commercial pace.

Asia-Pacific is projected to expand at 21.15% CAGR through 2031, giving it the fastest pace of growth in the botanicals and acupuncture market size. The region benefits from deeper familiarity with traditional care systems, larger practitioner bases in several countries, and stronger everyday use of botanicals in health routines. Kracie Pharmaceutical said in December 2025 that Japan's medical-use kampo market had expanded for 6 consecutive years, with younger adults driving strong demand for stress-related formulations. This supports the view that Asia-Pacific combines established traditional demand with new consumer adoption patterns, which gives the botanicals and acupuncture market a broad growth platform.

Europe remains an important part of the botanicals and acupuncture market, but it is operating with a tighter and more uneven regulatory backdrop than some other regions. The October 2025 WHO International Regulatory Cooperation for Herbal Medicines meeting showed continued work on the International Herbal Pharmacopoeia and the Global Traditional Medicine Strategy 2025-2034, which highlights both the need for and the absence of full harmonization. The Middle East and Africa and South America are smaller in current scale, but both regions offer room for sourcing, wellness services, and future expansion. The botanicals and acupuncture market is therefore geographically diverse, but regional growth still depends heavily on how quickly care access, evidence standards, and product rules move closer together.

List of Companies Covered in this Report:

• 3B Scientific
• AcuMedic Ltd.
• Archer Daniels Midland Company
• Bio-Botanica Inc.
• Bionorica SE
• Blue Sky Botanics Ltd.
• Dohler GmbH
• Givaudan SA
• Indena S.p.A.
• International Flavors & Fragrances Inc.
• Kerry Group plc
• Martin Bauer Group
• Naturex SA
• Sabinsa Corporation
• SEIRIN Corporation
• Symrise AG
• Synthite Industries Ltd.
• Wuxi Jiajian Medical Instruments Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support